Tag Archives: EPA: Eicosapentaenoic Acid

Omega 3 Fatty Acid for Prevention of Cognitive Decline and Dementia (Cochrane Database / NHS Choices / AHRQ)

[A version of this item appears in: Dementia: the Latest Evidence Newsletter (RWHT), Volume 3 Issue 1, August 2012]. Summary Diets high in omega-3 long-chain polyunsaturated fatty acids (PUFA) had recently been suggested in some quarters to help protect people … Continue reading

Posted in For Doctors (mostly), For Researchers (mostly), In the News, NHS Digital (Previously NHS Choices), Non-Pharmacological Treatments, Quick Insights, Systematic Reviews, Universal Interest | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , | Leave a comment

Omega 3 Fatty Acids For Treatment of Dementia and Cognitive Impairment

Abstract This is the protocol for a Cochrane systematic review which is in progress. The main objective of this research is to evaluate the effect of omega 3 fatty acids supplementation on cognitive functions in patients with dementia or mild cognitive … Continue reading

Posted in For Researchers (mostly), Non-Pharmacological Treatments, Systematic Reviews, Universal Interest | Tagged , , , , , , , , , , , | Leave a comment